Association Between Anti-cyclic Citrullinated Protein Antibodies and Extra-articular Manifestations in Rheumatoid Arthritis
Authors: Kasama, Tsuyoshi; Kusaba, Atsushi; Kanbe, Tomohiko; Sunami, Hiroshi; Kondo, Saiji; Yamashita, Hiroki; Isozaki, Takeo; Yajima, Nobuyuki
Source journal: Clinical medicine insights. Arthritis and musculoskeletal disorders (2026-01-01)
DOI: 10.1177/11795441261497736
Abstract
BACKGROUND: Anti-cyclic citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are established serological markers in rheumatoid arthritis (RA). However, their specific roles in the development of extra-articular manifestations (EAMs) remain a subject of debate. OBJECTIVES: This study aimed to quantitatively evaluate ACPA and RF titers and determine their predictive value for specific EAMs, particularly rheumatoid vasculitis (RV) and interstitial lung disease (ILD). DESIGN: This research was designed as a retrospective cross-sectional study. METHODS: We analyzed clinical data from 205 patients with RA, categorized into an RA control group (n = 129) and an RA-EAM group (n = 76). Serum ACPA and RF titers were measured using a second-generation chemiluminescent enzyme immunoassay. To validate the findings, a post hoc power analysis was conducted. Receiver operating characteristic (ROC) curves were generated to determine optimal ACPA cutoff values for predicting RV and ILD. RESULTS: Serum ACPA titers, but not RF titers, were significantly elevated in patients with ILD and RV compared with those without EAMs (P < .01). To evaluate the diagnostic utility of serum ACPA titers, ROC curve analysis was performed. Receiver operating characteristic curve analysis showed that ACPA had moderate discriminative ability for identifying RV (AUC = 0.755; 95% CI, 0.61-0.88). The optimal cutoff determined by Youden's index was 120 U/mL (sensitivity 90.0%, specificity 59.7%). For ILD, the AUC was 0.693 (95% CI, 0.59-0.78), with an optimal cutoff value of 42 U/mL (sensitivity 85.0%, specificity 46.5%). ACPA levels in patients with other EAMs did not differ significantly from controls. CONCLUSION: Our results demonstrated that serum ACPA levels were significantly higher in patients with RA-associated ILD and RV compared with those without systemic involvement. Notably, this association was not observed for RF titers. These findings suggest that high-titer ACPAs may serve as a more specific immunological marker for these severe complications than traditional RF. REGISTRATION: Not applicable.
Related topics
Related open access articles
- Can dietary intervention be an auxiliary therapy for Rheumatoid Arthritis?
- IMMUNE RELATED DISEASES AND THEIR RELATIONSHIP WITH THE GENETIC VARIABILITY WITHIN THE ADENOSINE DEAMINASE GENE
- ENTEROPARASITES, RESPIRATORY ALLERGY AND OTHER SIGNS AND SYMPTOMS IN CHILDS AND YOUTH POPULATION OF RECÔNCAVO OF BAHIA – BRAZIL
- Proctocolitis in a child treated with oral immunotherapy for cow’s milk allergy
- Non-ionic Contrast Allergy Manifesting as Stevens Johnson Syndrome and Erythema Multiforme
- The Differentiation and Roles of inflammatory Cytokine in the initiation of Inflammatory Bowel Diseases (IBD)
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.